You are here

  • Home
  • Archive
  • Volume 22, Issue 1
  • Economic impact of antifungal treatment in IFD by Candida species: anidulafungin administration as a cost-effective alternative for critical care patients

Citation Tools

Article menu

Download PDFPDF

Original article
Economic impact of antifungal treatment in IFD by Candida species: anidulafungin administration as a cost-effective alternative for critical care patients
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Cattel F, Ancona F, Chiumente M, et al
Economic impact of antifungal treatment in IFD by Candida species: anidulafungin administration as a cost-effective alternative for critical care patients
European Journal of Hospital Pharmacy 2015;22:12-17.